Three oncology organizations weigh in on the CMS Medicare Physician Fee Schedule final rule for 2026, highlighting key pros and cons. Medscape Medical News Source link : https://www.medscape.com/viewarticle/major-cancer-organizations-react-cmss-2026-final-rule-2025a1000z7n?src=rss Author :...

Postpartum use of domperidone to increase milk production in breastfeeding is not correlated with increased mental health-related emergency department visits. Medscape Medical News Source link : https://www.medscape.com/viewarticle/domperidone-safety-postpartum-mental-health-findings-2025a1000z7k?src=rss Author : Publish...

The combination of gastric electrical stimulation and pyloroplasty produces better outcomes than pyloroplasty alone in patients with refractory gastroparesis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/pyloroplasty-gastric-electric-stimulation-treats-2025a1000z7j?src=rss Author : Publish date...

(MedPage Today) -- Six midlife symptoms of depression were tied to an increased risk of dementia, prospective research from the Whitehall II cohort showed. Depressive symptoms that emerged as midlife...

(MedPage Today) -- Decades-old fears of heart risks from eating saturated fats appeared to have been overblown for many individuals, according to a meta-analysis of randomized trials. Across 17 studies,...

(MedPage Today) -- The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced...

(MedPage Today) -- An aspiring neurosurgeon and a student leader of Brown University's campus Republicans were in a study group preparing for an economics final, with the end of the...

(MedPage Today) -- A smartphone-delivered digital cognitive behavioral therapy (CBT) intervention improved generalized anxiety disorder symptoms in adults, a randomized trial showed. Among 351 participants, 71% who engaged in a...

(MedPage Today) -- After finding abnormalities on low-dose CT lung cancer screening, many patients don't get the recommended level of follow-up care, a Medicare-linked registry analysis showed. Only 59.7% of...

(MedPage Today) -- The FDA approved trastuzumab deruxtecan (T-DXd; Enhertu) in combination with pertuzumab (Perjeta) for the first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer. Approval was...

(MedPage Today) -- The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin...

(MedPage Today) -- While most cannabis retailers recommended women not use blunts or tobacco while pregnant, about one in five suggested prenatal cannabis use was safe, according to a cross-sectional...

(MedPage Today) -- Rates of postpartum hemorrhage and severe postpartum hemorrhage were markedly higher with the use of objective blood loss assessment methods, suggesting that subjective assessment methods may be...

(MedPage Today) -- The scientifically unsound "Make America Healthy Again" (MAHA) initiative is devastating our country's scientific infrastructure, medical research capacity, epidemiologic surveillance, and public health response capacity. MAHA... Source...

(MedPage Today) -- Editor's Note: This will be David Nash's final "Focus on Policy" column for MedPage Today. Nash has been a pioneer in the field of population health, pushing...

(MedPage Today) -- Under a program designed to accelerate the approval of products that could address key national priorities, the FDA awarded a national priority voucher to teclistamab (Tecvayli) in...

(MedPage Today) -- The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2-mutated metastatic castration-sensitive prostate cancer (mCSPC), the agency announced on Friday. The once-daily,...

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-first-class-drug-generalized-myasthenia-gravis-2025a1000z6f?src=rss Author : Publish...

(MedPage Today) -- The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced. The rapid-acting L-type calcium channel blocker is indicated......

(MedPage Today) -- All-oral therapies provide an attractive treatment option for patients with relapsed/refractory multiple myeloma, given their administration, the convenience of outpatient dosing, and the decreased need for hospital...